SmartfIRE Clinical Data: 12-month Safety and Efficacy of the Dual Energy THERMOCOOL SMARTTOUCH SF Catheter
In this chapter, Dr Arian Sultan and Prof Daniel Scherr introduce the SmartfIRE study, evaluating the Dual Energy THERMOCOOL SMARTTOUCH™ SF Platform for pulmonary vein isolation in the treatment of paroxysmal AF. Prof Scherr highlights the value of following an index guided optimised dual energy workflow for ablation. At 12 months, the study showed 87% freedom from arrhythmia when following the recommended workflow along with no PF-related complications and an overall complication rate of 3.6%, demonstrating optimised results when following an optimised workflow.
In this three-part peer-to-peer discussion, Dr Arian Sultan (Asklepios Clinic Hamburg, Hamburg, DE) and Prof Daniel Scherr (Medical University of Graz, Graz, AT) review the SmartfIRE study, presenting 12-month safety and efficacy data for the THERMOCOOL SMARTTOUCH™ SF Dual Energy Platform in paroxysmal AF.
The series opens with an overview of the study design, recommended workflow and key results that demonstrated an 87% optimised 12-month success rate along with a 3.6% safety rate with zero PF-related events.
Later chapters focus on study insights, and the practical use of the Dual Energy THERMOCOOL SMARTTOUCH™ SF Platform.
Disclosure: Drs Arian Sultan and Daniel Scherr are compensated by and presenting on behalf of Biosense Webster, Inc., and must present information in accordance with applicable regulatory requirements.
The catheter and system are approved for use in EMEA only.
M_US_ELP_THER_406735
More from this programme
Part 1
Study Introduction and Overview
In this chapter, Dr Arian Sultan and Prof Daniel Scherr introduce the SmartfIRE study, evaluating the Dual Energy THERMOCOOL SMARTTOUCH™ SF Platform for pulmonary vein isolation in the treatment of paroxysmal AF. Prof Scherr highlights the value of following an index guided optimised dual energy workflow for ablation. At 12 months, the study showed 87% freedom from arrhythmia when following the recommended workflow along with no PF-related complications and an overall complication rate of 3.6%, demonstrating optimised results when following an optimised workflow.
| 1 session | |
| Study Introduction and Overview | Watch now |
Part 2
Study Learnings and Insights
Dr Arian Sultan and Prof Daniel Scherr review key safety findings from the SmartfIRE study. Zero PF-related safety events were observed and key workflow learnings were gained from the investigation of the limited safety events. The discussion highlights the versatility of the dual-energy catheter for both PVI and CTI ablation and reinforces the strong safety profile of this approach.
| 1 session | |
| Study Learnings and Insights | Watch now |
Part 3
DE STSF Tips and Tricks
Dr Sultan and Prof Scherr discuss practical use of the Dual Energy THERMOCOOL SMARTTOUCH™ SF Platform. They highlight the value of measurable parameters – contact force, interlesion distance and ablation index – for guiding pulsed field ablation within a familiar workflow. Prof Scherr advises starting with 10g of contact force when starting ablation and Dr Sultan reinforces this approach with the discussion demonstrating confidence in durable lesion creation, even in difficult cases.
| 1 session | |
| DE STSF Tips and Tricks | Watch now |
Faculty Biographies
Arian Sultan
Asklepios Clinic Hamburg, Hamburg, DE
Prof Sultan graduated in 2004 from Medical School University of Hamburg, and completed a Doctoral Thesis in 2007. Prof Sultan received Board Certification in Internal Medicine in 2012, and in 2015 Board Certification in invasive electrophysiology and device implantation. Since 2014 she has served as Senior Consultant University Heart Center Cologne, and since 2019 as Deputy Head of the Department of Electrophysiology at the University Heart Center Cologne. Now she is the Head of EP at St Georg Heart Center, Asklepios Hamburg.
Daniel Scherr
Associate Professor
Prof Daniel Scherr is an Associate Professor in the Clinical Department of Cardiology at the Medical University of Graz, Graz, Austria. His research interests include cardiology, electrophysiology, telemedicine and intensive care. He is serving as an editorial member and reviewer in several international reputed journals.